Breaking News

Financial Report: Quintiles

By Kristin Brooks | February 13, 2014

Revenues up 8% in the quarter

4Q Revenues: $1.4 billion (+8%)
4Q Earnings: $72.9 million (+109%)
FY Revenues: $5.1 billion (+5%)
FY Earnings: $226.0 (+28%)
Comments: New business wins were $1.3 billion and $4.9 billion for the quarter and year ended December 31, 2013, respectively, representing a book-to-bill ratio of 1.29 for both the quarter and year, and contributed to an ending backlog of $9.9 billion. Product Development revenues were $775 million in the quarter, up 10%, and $2.9 billion for the year, up 7%. Integrated Healthcare Services revenue was $228.9 million in the quarter, down 6%, and $888.6 million for the year, down 8%.
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks